Back to Adven® or All Pills & Capsules

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This page was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Dosing Look-Up Table (Estimated)

0.01/g0.25/mg THC0.5/mg CBD
0.05/g1.25/mg THC2.5/mg CBD
0.1/g2.5/mg THC5/mg CBD
0.15/g3.75/mg THC7.5/mg CBD
0.2/g5/mg THC10/mg CBD
0.25/g6.25/mg THC12.5/mg CBD
0.3/g7.5/mg THC15/mg CBD
/gCalculate THCCalculate CBD

Please note values above are based on registered THC/CBD percentages, subject to ±10% allowed variance. Values provided are 'best case', losses to air during vaporisation or combustion will always occur.

Medication Details

Brand
United States Adven®
Designation
T2.5:C5
Chemotype
Type II: THC/CBD Mix
THC Potential Range (±10%)
2.25-2.75mg
CBD Potential Range (±10%)
4.5-5.5mg
Cultivated in
Flag of Portugal Portugal
Imported by
United Kingdom Curaleaf Laboratories
Imported as
Schedule I: Raw Material
Formulated in
Flag of Spain Spain
Formulated by
United Kingdom Curaleaf Laboratories

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: Available

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Main Partner Pharmacy

Pharmacy Distributor

Dispensing Patient Pharmacies

Product Description Video Reviews0 Patient Reviews

About Cairo

EMT2Sativa Hybrid

A proprietary strain from Adven GmbH.

Proprietary Strain

Bred in-house by the cultivator at Curaleaf's Terra Verde facility. After some time MedBud can confirm this strain is a direct hybrid of two Sativa-dominant Hybrids, Amnesia Haze and White Widow. Because of this, we do not follow the manufacturer's classification as an Indica product - listing instead as a Hybrid, which also likely shows more Sativa dominant traits as reported by many patients.

Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).

United States About Adven GmbH

Adven® Logo

We are European leaders in production and research of medicinal cannabis. With our products and in-depth knowledge of cannabinoid therapies, we support medical professionals with individualised treatments for patients.

We are European leaders in the production and research of medicinal cannabis. With our products and in-depth knowledge of cannabinoid therapies, we support medical professionals in the individual treatment of people. Our mission: to ensure medical care, education within a professional framework and natural cultivation under the highest possible quality standards. Cannabis is one of the oldest medicinal plants in the world and can improve the quality of life for people with acute and chronic diseases.

We value sustainable cultivation and already ensure organic quality for numerous cannabis varieties. All of our production processes are certified according to GMP (Good Manufacturing Practice) standards. We commit ourselves to the strictest quality standards. Independent controls confirm: Our products in the area of ​​full-spectrum cannabis extracts and flowers are single-variety, of the highest quality and reliably available.

adven.de

  Information provided is partially community sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)